RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $796,402 | -33.0% | 94,697 | 0.0% | 0.02% | -20.0% |
| Q2 2023 | $1,189,394 | -23.7% | 94,697 | 0.0% | 0.02% | -16.7% |
| Q1 2023 | $1,559,660 | +10.2% | 94,697 | 0.0% | 0.02% | +14.3% |
| Q4 2022 | $1,414,773 | -33.2% | 94,697 | 0.0% | 0.02% | -19.2% |
| Q3 2022 | $2,118,000 | +33.5% | 94,697 | 0.0% | 0.03% | +36.8% |
| Q2 2022 | $1,586,000 | -44.0% | 94,697 | 0.0% | 0.02% | -9.5% |
| Q1 2022 | $2,834,000 | -2.5% | 94,697 | 0.0% | 0.02% | +23.5% |
| Q4 2021 | $2,908,000 | -2.6% | 94,697 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $2,986,000 | -13.8% | 94,697 | 0.0% | 0.02% | -26.1% |
| Q2 2021 | $3,465,000 | +5.8% | 94,697 | 0.0% | 0.02% | -37.8% |
| Q1 2021 | $3,274,000 | -16.8% | 94,697 | 0.0% | 0.04% | -62.2% |
| Q4 2020 | $3,936,000 | -2.4% | 94,697 | 0.0% | 0.10% | -58.3% |
| Q3 2020 | $4,033,000 | – | 94,697 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |